Chemoradiotherapy for high-risk stage II laryngeal cancer.
Satoshi HamauchiTomoya YokotaYusuke OnozawaHirofumi OgawaTsuyoshi OnoeTomoyuki KamijoYoshiyuki IidaTetsuro OnitsukaHirofumi YasuiPublished in: International journal of clinical oncology (2020)
CRT may provide better locoregional control than RT alone in high-risk stage II laryngeal cancer.